Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03115710 · ClinicalTrials.gov registry record
The K-Map Study, Global Prevalence of KC
A clinical trial of Keratoconus, sponsored by University Hospital, Geneva.
- Recruiting
- Registry status
- 20,000
- Enrollment target
- 12
- Study locations
NCT03115710 is a study of Keratoconus that is actively recruiting participants, run by University Hospital, Geneva. The registered enrollment target is 20,000 participants, above the 228-participant average among 21 other Keratoconus trials with a reported enrollment target (8672% higher). The trial reports 12 study locations across 2 states.
The verdict
NCT03115710, a study of Keratoconus, is actively recruiting participants, sponsored by University Hospital, Geneva.
- RECRUITING
- Registry status
- 20,000 participants
- Enrollment target
- 12
- Study locations
Study Summary
Keratoconus is a ocular disease classified under ectatic diseases which often results in bilateral and asymmetrical corneal distortion. It usually affects patients at young age and can cause severe visual loss. The overall goal of this study is to assess the prevalence of keratoconus (KC) in children and adolescents in various regions of the world based on modern tomographic imaging methods, and to verify whether the occurrence rates reported from literature should be corrected. Our hypothesis is that the prevalence of the disease is much higher than that traditionally reported. At each site, corneal tomography examinations (Pentacam) will be performed bilaterally in children and adolescents, who are not ill or with any ophthalmological symptom. The population to be studied will be composed of children and adolescents on medical visits for non-ophthalmologic reasons, aged between 6 and 20 years. Multiple cities, from different continents (North America, South America, Asia and Europe) will participate.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Rotating Scheimpflug camera (Pentacam HR)
Study Locations (12)
Other
- Eye Hospital of Wenzhou Medical College - Wenzhou
- - Zagreb
- - Alexandria
- - Homburg
- - Isfahan
- - Amman
- - Monterrey
- - Lima
- Ufa Eye Research Intitute - Ufa
- King Saud University - Riyadh
- - Bukhara
California
- USC Roski Eye Institute - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,000 participants |
| Start Date | 2015-12-28 |
| Est. Completion | 2030-02-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03115710
The ClinicalTrials.gov registry entry for NCT03115710 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 20,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 228-participant average among 21 other Keratoconus trials with a reported enrollment target (8672% higher). The listed sponsor is University Hospital, Geneva, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Keratoconus appearing as the primary indexed condition, and to 1 intervention - of which Rotating Scheimpflug camera (Pentacam HR) is the first listed.
NCT03115710 reports 12 study locations spanning 2 distinct geographic areas - top geographies include Other, California.
Frequently Asked Questions
What is clinical trial NCT03115710 about?
NCT03115710 is a clinical study titled "The K-Map Study, Global Prevalence of KC". Keratoconus is a ocular disease classified under ectatic diseases which often results in bilateral and asymmetrical corneal distortion. It usually affects patients at young age and can cause severe visual loss. The overall goal of this study is to assess the prevalence of keratoconus (KC) in childr...
What is the current status of trial NCT03115710?
This trial is currently recruiting. The enrollment target is 20,000 participants. The study started on 2015-12-28. Estimated completion is 2030-02-01.
What conditions does trial NCT03115710 study?
This clinical trial studies the following conditions: Keratoconus.
What interventions are being tested in trial NCT03115710?
The interventions under investigation include: Rotating Scheimpflug camera (Pentacam HR) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03115710?
This trial is sponsored by University Hospital, Geneva, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03115710 being conducted?
This trial has 12 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Keratoconus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
RECRUITING
-
OCT in Diagnosis of Irregular Corneas
RECRUITING
-
Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure vs. a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases
RECRUITING · Phase 3
-
Collagen Cross-linking in Keratoconus
RECRUITING · NA
-
Corneal Elastography and Patient Specific Modeling
RECRUITING
-
Compassionate Use Study of Epi-ON Corneal Collagen Crosslinking Performed Using UVA Exposure on Eyes With Ectatic Corneal Diseases for Subjects With Down Syndrome
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.